Short answer
Globe Life (GL) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Globe Life announced third-quarter 2026 financial results on October 21, 2026.
Globe Life 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Globe Life announced third-quarter 2026 financial results on October 21, 2026
- Detailed results and management commentary are in Exhibit 99.1, the accompanying press release
- Disclosure furnished under Form 8-K Item 2.02, generally not treated as filed under Exchange Act Section 18
Item EX-99.1 · Exhibit EX-99.1
- Q3 net operating income $4.84 per share, up 1%; net income $4.62, down from $4.73
- Premium revenue rose 7% to $1.31 billion, led by health premium growth of 16%
- Life underwriting margin fell 5% to $458.2 million, while health margin increased 7% to $115.6 million
- United American health underwriting loss reflected approximately $16 million of Evry claims and $7 million of excess Medicare Supplement claims
- 2026 earnings guidance reduced to $15.35 to $15.65; 2027 guidance $16.10 to $17.10, midpoint growth 7.1%
- Repurchased 1.1 million shares for $185 million; full-year buyback outlook increased to $725 million to $775 million
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Globe Life 8-K filings
Get the next GL 8-K as it lands
Follow GL for push alerts, or ask the research agent what this filing means.